Drugs in the amorphous form are loaded into porous silica particles, which provide a maintained concentration gradient for skin delivery.
Fred Monsuur
Advertisement
Fred Monsuur is excipient development manager at Grace Materials Technologies, Germany.
Articles by Fred Monsuur
Advertisement
Latest Updated Articles
A Novel Amorphous Delivery System to the Skin for Poorly Soluble ActivesPublished: June 2nd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AI-Powered Digital Twins Achieve High Accuracy in Human Lung Function Forecasting
2
Defining An Agitation Model for Early-Stage, High Concentration Biologics Formulation Development
3
From Lab to Patient: The Critical Role of Supply Chain & Distribution in the Life Sciences
4
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
5
